FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4321016095> ?p ?o ?g. }

• W4321016095 endingPage "6" @default.
• W4321016095 startingPage "1" @default.
• W4321016095 abstract "Background. Cutaneous warts are common epidermal proliferations caused by human papillomavirus (HPV). We aimed to determine the safety and efficacy of topical calcipotriol for the treatment of cutaneous warts. Methods. This assessor-blind randomized placebo-controlled trial included 56 patients with cutaneous warts referred to a dermatology clinic from January 21 to March 20, 2020. Patients were randomized into two groups (n = 28). One group received calcipotriol 0.05% ointment twice a day on the lesions with a uniform thickness of 1 mm, and the other group received a placebo. The duration of treatment was twomonths, which continued for another two months if resolution did not occur. The primary outcome was complete response to treatment evaluated four months after the initiation of therapy. Secondary outcomes were the number and size of warts assessed at 1, 2, and 4 months and adverse events, including erythema, pruritus, burning sensation, and scaling. Results. Patients in both groups were comparable regarding previous treatment, underlying disease, and disease duration. However, patients in the control group were older. Also, a higher proportion of patients in the calcipotriol group were male and had warts on their palms and toes. Moreover, a higher percentage of controls had moderate disease. The mean number and the size of lesions did not differ between groups before intervention; however, both were significantly lower in the calcipotriol group than in controls at 1st, 2nd, and 4th months. In addition, complete response to treatment was significantly higher in the calcipotriol group (85.7% vs. 16%; <math xmlns=http://www.w3.org/1998/Math/MathML id=M1> <mi>P</mi> <mo><</mo> <mn>0.001</mn> </math> ). On the other hand, the frequency of adverse events was not different between groups ( <math xmlns=http://www.w3.org/1998/Math/MathML id=M2> <mi>P</mi> <mo>=</mo> <mn>0.352</mn> </math> ). Conclusions. Calcipotriol can be considered a safe and effective treatment option for cutaneous warts. Trial Registration: This trial is registered with IRCT20170818035762N2, available at https://www.irct.ir/trial/45716." @default.
• W4321016095 created "2023-02-17" @default.
• W4321016095 creator A5011597567 @default.
• W4321016095 creator A5028189683 @default.
• W4321016095 creator A5045614173 @default.
• W4321016095 creator A5070757419 @default.
• W4321016095 creator A5086388964 @default.
• W4321016095 creator A5090057212 @default.
• W4321016095 date "2023-02-16" @default.
• W4321016095 modified "2023-10-14" @default.
• W4321016095 title "Topical Calcipotriol for the Treatment of Cutaneous Warts: An Assessor-Blind Randomized Placebo-Controlled Trial" @default.
• W4321016095 cites W1645776849 @default.
• W4321016095 cites W1944451893 @default.
• W4321016095 cites W2000736162 @default.
• W4321016095 cites W2014952073 @default.
• W4321016095 cites W2038547803 @default.
• W4321016095 cites W2039035427 @default.
• W4321016095 cites W2124580054 @default.
• W4321016095 cites W2162510620 @default.
• W4321016095 cites W2739885626 @default.
• W4321016095 cites W2931871082 @default.
• W4321016095 cites W3012107617 @default.
• W4321016095 cites W3016163103 @default.
• W4321016095 cites W3044880461 @default.
• W4321016095 cites W3154403193 @default.
• W4321016095 doi "https://doi.org/10.1155/2023/3427026" @default.
• W4321016095 hasPublicationYear "2023" @default.
• W4321016095 type Work @default.
• W4321016095 citedByCount "0" @default.
• W4321016095 crossrefType "journal-article" @default.
• W4321016095 hasAuthorship W4321016095A5011597567 @default.
• W4321016095 hasAuthorship W4321016095A5028189683 @default.
• W4321016095 hasAuthorship W4321016095A5045614173 @default.
• W4321016095 hasAuthorship W4321016095A5070757419 @default.
• W4321016095 hasAuthorship W4321016095A5086388964 @default.
• W4321016095 hasAuthorship W4321016095A5090057212 @default.
• W4321016095 hasBestOaLocation W43210160951 @default.
• W4321016095 hasConcept C126322002 @default.
• W4321016095 hasConcept C141071460 @default.
• W4321016095 hasConcept C142724271 @default.
• W4321016095 hasConcept C16005928 @default.
• W4321016095 hasConcept C168563851 @default.
• W4321016095 hasConcept C197934379 @default.
• W4321016095 hasConcept C204787440 @default.
• W4321016095 hasConcept C27081682 @default.
• W4321016095 hasConcept C2776009542 @default.
• W4321016095 hasConcept C2779121184 @default.
• W4321016095 hasConcept C2779136573 @default.
• W4321016095 hasConcept C2780564577 @default.
• W4321016095 hasConcept C2994532551 @default.
• W4321016095 hasConcept C71924100 @default.
• W4321016095 hasConceptScore W4321016095C126322002 @default.
• W4321016095 hasConceptScore W4321016095C141071460 @default.
• W4321016095 hasConceptScore W4321016095C142724271 @default.
• W4321016095 hasConceptScore W4321016095C16005928 @default.
• W4321016095 hasConceptScore W4321016095C168563851 @default.
• W4321016095 hasConceptScore W4321016095C197934379 @default.
• W4321016095 hasConceptScore W4321016095C204787440 @default.
• W4321016095 hasConceptScore W4321016095C27081682 @default.
• W4321016095 hasConceptScore W4321016095C2776009542 @default.
• W4321016095 hasConceptScore W4321016095C2779121184 @default.
• W4321016095 hasConceptScore W4321016095C2779136573 @default.
• W4321016095 hasConceptScore W4321016095C2780564577 @default.
• W4321016095 hasConceptScore W4321016095C2994532551 @default.
• W4321016095 hasConceptScore W4321016095C71924100 @default.
• W4321016095 hasFunder F4320322406 @default.
• W4321016095 hasLocation W43210160951 @default.
• W4321016095 hasOpenAccess W4321016095 @default.
• W4321016095 hasPrimaryLocation W43210160951 @default.
• W4321016095 hasRelatedWork W1987326205 @default.
• W4321016095 hasRelatedWork W1995511711 @default.
• W4321016095 hasRelatedWork W2015819023 @default.
• W4321016095 hasRelatedWork W2077977577 @default.
• W4321016095 hasRelatedWork W2098451303 @default.
• W4321016095 hasRelatedWork W2119329430 @default.
• W4321016095 hasRelatedWork W2135738097 @default.
• W4321016095 hasRelatedWork W2138396424 @default.
• W4321016095 hasRelatedWork W2621540362 @default.
• W4321016095 hasRelatedWork W2189473566 @default.
• W4321016095 hasVolume "2023" @default.
• W4321016095 isParatext "false" @default.
• W4321016095 isRetracted "false" @default.
• W4321016095 workType "article" @default.